Key points are not available for this paper at this time.
Introduction Artificial intelligence (AI) and machine learning (ML) have the potential to revolutionize the management of febrile neutropenia (FN) and drive progress toward personalized medicine.
Gallardo‐Pizarro et al. (Fri,) studied this question.